National Bank of Canada lifts Jamieson Wellness price target to C$45 from C$40.5

National Bank of Canada lifts Jamieson Wellness price target to C$45 from C$40.5

National Bank of Canada Raises Jamieson Wellness Price Target to C$45
February 22, 2026

National Bank of Canada has revised its price target for Jamieson Wellness Inc. (TSE: JWEL), lifting it to C$45 from C$40.50, while maintaining its "outperform" rating for the vitamin and supplement retailer according to the bank's Q2 analysis. The adjustment follows the company's second-quarter financial results, which the bank cited as a key factor in its revised assessment.

Jamieson Wellness, a leading player in the Canadian natural health products market, reported earnings in line with expectations during its Q2 update. While specific details of the bank's analysis were not disclosed in publicly available materials, the upgraded target suggests improved confidence in the company's operational performance or growth prospects. The new C$45 target implies approximately 22% upside potential from the stock's closing price of C$36.85 on February 21, 2026.

The move aligns with broader analyst activity surrounding the stock. TipRanks data indicates ongoing interest in Jamieson Wellness, though detailed forecasts remain limited without enabling JavaScript on certain platforms. Meanwhile, recent analyst coverage, including upgrades and downgrades across other sectors, reflects dynamic sentiment in the market.

Investors should note that National Bank's revised target does not necessarily signal immediate share price movement. The stock's performance will depend on broader market conditions, competitive dynamics, and Jamieson Wellness's ability to execute its strategic priorities. As of February 22, 2026, the company's shares traded with mixed momentum, reflecting cautious optimism among traders.

For stakeholders, the updated rating underscores the importance of monitoring quarterly results and analyst commentary for further clues about the stock's trajectory. No promotional language or speculative claims are intended in this report, which is strictly based on disclosed information.

TipRanks. Jameson Wellness Inc (JWEL) Stock Forecast: TipRanks
Marketscreener. Jameson Wellness Outperform Rating Confirmed: Marketscreener